Mumbai-headquartered prescribed drugs main Cipla introduced on Tuesday that its Vice Chairman, MK Hamied, has stepped down as a consequence of age- and health-related causes. Hamied, who’s a part of the second technology of the drug maker’s founding household, will resign efficient from the shut of enterprise hours on October 29, in keeping with a regulatory submitting by the corporate after market hours on September 3.
“It’s with a heavy coronary heart that I write to formally announce my resignation from the place of Vice Chairman and Non-Govt Director of the Firm with impact from shut of enterprise hours on twenty ninth October 2024, as a consequence of age and well being,” Hamied wrote in a letter addressed to the corporate’s board members.
“These previous 47 years at Cipla have been actually a outstanding chapter in my life. Over the a long time, I’ve seen the Firm develop and evolve in methods I’m immensely pleased with. I want to specific my deepest gratitude to all my fellow Board members for his or her unwavering help and steering,” he wrote.
“I want Cipla continued success sooner or later, and I hope to see its function of ‘Caring for Life’ on the coronary heart of the whole lot that it does,” the letter talked about.
Cipla stated its board authorized the appointment of Kamil Hamied as Non-Govt Director, with impact November 1, 2024.
Who’s MK Hamied?
Hamied is a science graduate from Bombay College.
He has huge and diversified expertise in all features of Cipla together with manufacturing, technical areas, high quality administration, and common administration.
Upon attaining retirement because the Govt Vice-Chairman on March 31, 2014, Hamied continued to be Vice-Chairman in Non-Govt position with impact from April 1, 2014.
Cipla Shares
Earlier on Tuesday, Cipla shares ended 0.4 per cent increased at Rs 1,652.4 apiece on BSE.
Catch all of the newest inventory market updates right here. For all different information associated to enterprise, market, tech and auto, go to Zeebiz.com.